PHOTOLITEC LLC

CLARENCE, NY · Founded 2007 · Biotech · Private

Photobac, a near-infrared photosensitizer molecule for cancer imaging and photodynamic therapy

Claim this profile

Follows are private to you and power your alerts

Updated Oct 16, 2026 · photolitec.org

Sector: Biotech
Headquarters: CLARENCE, NY
Founded: 2007
Latest Form D: $530K, Feb 2011
Total capital: $6.4M

Federal grants: $4M; 4 awards · 2015–2022; Rank in peer group#69 of 326
Private capital raised: $530K; 1 Form D · last Feb 2011; 188 months since last filing
Federal contracts: $1.9M; 1 award · Health and Human S; Rank in Biotech#141 of 4373
Granted patents: 1; 2 pending · first 2021; Rank in peer group#80 of 326

Capital timeline

Latest events

Mar 2022Federal grantHealth and Human S · Phase II · Treatment of Glioblastoma: the combination of fluorescence guided surgery and photodynamic therapy$961K
Sep 2020Federal grantHealth and Human S · Phase II · Treatment of Glioblastoma: the combination of fluorescence guided surgery and photodynamic therapy$400K
Sep 2017Federal contractHealth and Human S · Igf::ot::igf SBIR Phase II Topic 357: Image-guided Photodynamic Therapy In Combination With Chemotherapy Of Lung Cancer$1.9M
Jul 2015Federal grantHealth and Human S · Phase II · Fluorescence Image-Guided Near Infrared (NIR) Photodynamic Therapy (PDT) Agent$716K
Feb 2011Private capital raisedForm D · SEC · 1st filing$530K

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

1 record has no date or no amount, so it isn’t placed on the timeline.

Standing among 326 peers

Line = median

Biotech · Molecule

Federal grants#69 · top 21%
Granted patents#80 · top 25%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

Researcher links verified by same-company patents and grants

Ravindra K PandeyResearcherExecutive Officer, DirectorLinked by 1 patent
Scott E FriedmanDirectorNamed in SEC Form D filings

What it has protected

USPTO · 1 granted of 3

Aug 10, 2021GrantedEpidermal Growth Factor Receptor (egfr) Targeted PhotosensitizersUSPTOUS 11,083,793
PendingEpidermal Growth Factor Receptor (egfr) Targeted PhotosensitizersUSPTOApplication PCTUS2017066225
PendingTetrapyrollic Photosensitizers For Conjugation With Paa Nanoparticles For Tumor Treatment And ImagingUSPTOApplication PCTUS2013046537

GLYCAN THERAPEUTICS CORPORATIONSimilar federal contract value in Biotech · $1.9M in contracts
NAVIPOINT GENOMICS LLCSimilar federal contract value in Biotech · $1.9M in contracts
IDBIOLOGICS INCSimilar federal contract value in Biotech · $1.9M in contracts
MAXCYTE, INC.Similar federal contract value in Biotech · $1.9M in contracts
ABZYME THERAPEUTICS LLCSimilar federal contract value in Biotech · $1.8M in contracts
INTEGRATED RESEARCH ASSOCIATES, LLCSimilar federal contract value in Biotech · $1.8M in contracts

Regulatory activity · Biotech

Sector-level, not company-level

07 Jul 2026New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
30 Jun 2026Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
30 Jun 2026Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
29 Jun 2026Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
26 Jun 2026Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
26 Jun 2026Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through Oct 16, 2026. SBIR and STTR awards through Jul 3, 2026.